Title Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution
Authors Ling, Shaoping
Hu, Zheng
Yang, Zuyu
Yang, Fang
Li, Yawei
Lin, Pei
Chen, Ke
Dong, Lili
Cao, Lihua
Tao, Yong
Hao, Lingtong
Chen, Qingjian
Gong, Qiang
Wu, Dafei
Li, Wenjie
Zhao, Wenming
Tian, Xiuyun
Hao, Chunyi
Hungate, Eric A.
Catenacci, Daniel V. T.
Hudson, Richard R.
Li, Wen-Hsiung
Lu, Xuemei
Wu, Chung-I
Affiliation Univ Chinese Acad Sci, Beijing Inst Genom, Chinese Acad Sci, China Gastrointestinal Canc Res Ctr,Key Lab Genom, Beijing 100101, Peoples R China.
Sun Yat Sen Univ, Coll Ecol & Evolut, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.
Peking Univ, Key Lab Carcinogenesis & Translat Res, Canc Hosp, Beijing 100142, Peoples R China.
Univ Chicago, Dept Pediat, Chicago, IL 60637 USA.
Univ Chicago, Hematol Oncol Sect, Dept Med, Chicago, IL 60637 USA.
Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA.
Acad Sinica, Biodivers Res Ctr, Taipei 11529, Taiwan.
Keywords intratumor heterogeneity
genetic diversity
neutral evolution
cancer evolution
natural selection
INTRATUMOR HETEROGENEITY
CLONAL EVOLUTION
POPULATION-GENETICS
MOLECULAR EVOLUTION
CANCER EVOLUTION
SEQUENCING DATA
NEUTRAL THEORY
BREAST-CANCER
MUTATIONS
SELECTION
Issue Date 2015
Publisher PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Citation PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA.2015,112,(47),E6496-E6505.
Abstract The prevailing view that the evolution of cells in a tumor is driven by Darwinian selection has never been rigorously tested. Because selection greatly affects the level of intratumor genetic diversity, it is important to assess whether intratumor evolution follows the Darwinian or the non-Darwinian mode of evolution. To provide the statistical power, many regions in a single tumor need to be sampled and analyzed much more extensively than has been attempted in previous intratumor studies. Here, from a hepatocellular carcinoma (HCC) tumor, we evaluated multiregional samples from the tumor, using either whole-exome sequencing (WES) (n = 23 samples) or genotyping (n = 286) under both the infinite-site and infinite-allele models of population genetics. In addition to the many single-nucleotide variations (SNVs) present in all samples, there were 35 "polymorphic" SNVs among samples. High genetic diversity was evident as the 23 WES samples defined 20 unique cell clones. With all 286 samples genotyped, clonal diversity agreed well with the non-Darwinian model with no evidence of positive Darwinian selection. Under the non-Darwinian model, MALL (the number of coding region mutations in the entire tumor) was estimated to be greater than 100 million in this tumor. DNA sequences reveal local diversities in small patches of cells and validate the estimation. In contrast, the genetic diversity under a Darwinian model would generally be orders of magnitude smaller. Because the level of genetic diversity will have implications on therapeutic resistance, non-Darwinian evolution should be heeded in cancer treatments even for microscopic tumors.
URI http://hdl.handle.net/20.500.11897/416833
ISSN 0027-8424
DOI 10.1073/pnas.1519556112
Indexed SCI(E)
PubMed
Appears in Collections: 北京肿瘤医院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.